Gelatinase expression in ocular surface disorders.

Area of Science:

• Ophthalmology
• Biochemistry
• Molecular Biology

Background:

• Ocular surface disorders can lead to significant vision impairment.
• Matrix metalloproteinases (MMPs), including gelatinase A (MMP-2) and gelatinase B (MMP-9), play roles in tissue remodeling and degradation.
• Understanding MMP expression in ocular surface diseases is crucial for developing targeted therapies.

Purpose of the Study:

• To determine the expression levels and patterns of MMP-2 and MMP-9 in various ocular surface disorders.
• To investigate the presence of membrane type 1 (MT1)-MMP, an activator of MMP-2, in these conditions.

Main Methods:

• Analysis of tear samples using gelatin zymography to detect active and proforms of MMP-2 and MMP-9.
• Immunohistochemical examination of corneal and conjunctival tissues for MMP-2, MMP-9, and MT1-MMP.
• Reverse transcription-polymerase chain reaction (RT-PCR) to analyze mRNA expression of MMP-2, MMP-9, and MT1-MMP.

Main Results:

• Gelatin zymography revealed only proforms of MMP-2 and MMP-9 in normal controls, while active forms were detected in all patients.
• Immunohistochemistry showed MMP-2 in normal conjunctival epithelium, with MMP-2, MMP-9, and MT1-MMP present in the conjunctiva or cornea of patients.
• RT-PCR confirmed MMP-2 mRNA expression in normal controls and MMP-2, MMP-9, and MT1-MMP mRNA expression in patient samples.

Conclusions:

• MMP-2, MMP-9, and MT1-MMP are expressed in patients with ocular surface disorders.
• The expression of these gelatinases is significantly upregulated in ocular surface disease states.
• These findings suggest a role for MMPs in the pathogenesis of ocular surface disorders.